Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Believes In AI, But The Foundation Is Failing
Matt Lowe, chief strategy officer for MasterControl. The pharmaceutical industry's AI market is projected to grow from roughly $4 billion to $25.7 billion by 2030. Despite this surge, medicine makers have yet to see substantially shorter…
How Pharma Marketing Can Evolve Beyond Audience Targeting
Kamya Elawadhi is Co-Founder and President at Doceree. For the better part of a decade, pharma marketing has pursued one goal above all others: Know the audience. Look-alike models were built on claims data. National provider identifier-level…
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
The VanEck Pharmaceutical ETF (PPH +1.86%) offers concentrated exposure to established global drugmakers and higher yields, while the State Street SPDR S&P Biotech ETF (XBI -0.20%) provides a diversified, higher-volatility play on smaller-cap…
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Schott Pharma shares climbed more than 4% in early Frankfurt trading after Barclays upgraded the pharmaceutical packaging company to Overweight, citing improving fundamentals and expectations for accelerating earnings growth. Barclays believes…
Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited
Yapan Bio Private Limited specializes in process development, characterization, and phase I and II GMP manufacturing services for vaccines and biologics. Piramal has held a stake in Yapan Bio since 2021, enabling the Company to provide a broad…
Invesco MF launches India Pharma and Healthcare NFO
Invesco Mutual Fund has launched India Pharma and Healthcare Fund which will invest across pharmaceutical companies, hospitals, diagnostics, contract development and manufacturing organisations, contract research organisations, medical devices…
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
KLRA trades 29% below its IPO high but holds $1.17 billion in cash and carries a $42 analyst consensus price target. Merck's looming Keytruda revenue cliff and Novo Nordisk's need to defend Wegovy dominance make both natural buyers of Kailera's…
Idea First, Customer Second: The Mindset That Drives Innovation
Nataliya Andreychuk is the CEO of Viseven. She is a leading digital transformation evangelist for the pharma and life sciences industries. After years of conversations with pharmaceutical industry leaders across markets, I've come to a conclusion…
Nuvectis Pharma (NASDAQ:NVCT) Trading 6.2% Higher - What's Next?
Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) were up 6.2% during trading on Tuesday. The company traded as high as $19.68 and last traded at $20.2650. 27,455 shares were traded during mid-day trading, a decline of 83% from the…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Consensus Recommendation of 'Moderate Buy' by Analysts
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has earned an average rating of 'Moderate Buy' from the fourteen ratings firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock…
Rice Hall James & Associates LLC Purchases Shares of 300,650 Urogen Pharma $URGN
Rice Hall James & Associates LLC purchased a new stake in Urogen Pharma (NASDAQ:URGN - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 300,650 shares of…
The Manufacturers Life Insurance Company Has $196,000 Stock Holdings in Urogen Pharma $URGN
The Manufacturers Life Insurance Company decreased its position in Urogen Pharma (NASDAQ:URGN - Free Report) by 80.4% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 10,909 shares of the…
Indian Stock Market Declines: Crude Oil Spike, US Bond Yields, West Asia Tensions Impact Sentiment
Indian stock markets, including the Sensex and Nifty, opened lower as a significant jump in Brent crude oil prices above $91 per barrel, fuelled by escalating West Asia tensions and rising US bond yields, dampened investor sentiment. Indian…
'Sea Of Red': Futures Slide As Market Wakes Up To Soaring Bond Yields And Diesel Prices
US futures are a 'sea of red' (as Bloomberg describes it) in early trading as thin summer volumes persist, with the wrong kind of inflation coming to the fore and Monday's tech selloff weighing on sentiment despite bullish AI news. The recent…
The startup using AI to help rare disease families develop custom treatments
Nome is building an AI-powered drug development service for ultra-rare disease patients, helping families identify potential treatments and map out a path from diagnosis to clinical development. The startup targets patient groups often overlooked…
Receive a Daily briefing on Pharma Industry News
Get Started